Assertio Holdings Inc Sustainability Reports
Assertio Holdings, Inc. is a commercial-facing pharmaceutical company that acquires, licenses, and develops differentiated products. Its portfolio focuses on neurology, rheumatology, and pain and inflammation treatments.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
9 reports from 2014 to 2025
Company Profile
Assertio Holdings, Inc. is a commercial-facing pharmaceutical company that acquires, licenses, and develops differentiated products. Its portfolio focuses on neurology, rheumatology, and pain and inflammation treatments.
Reports
9 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
